Choline metabolism-based molecular diagnosis of cancer: an update

K Glunde, MF Penet, L Jiang, MA Jacobs… - Expert review of …, 2015 - Taylor & Francis
Abnormal choline metabolism continues to be identified in multiple cancers. Molecular
causes of abnormal choline metabolism are changes in choline kinase-α, ethanolamine …

Methods to Increase the Metabolic Stability of 18F-Radiotracers

M Kuchar, C Mamat - Molecules, 2015 - mdpi.com
The majority of pharmaceuticals and other organic compounds incorporating radiotracers
that are considered foreign to the body undergo metabolic changes in vivo. Metabolic …

MFSD7c functions as a transporter of choline at the blood–brain barrier

XTA Nguyen, TNU Le, TQ Nguyen, H Thi Thuy Ha… - Cell Research, 2024 - nature.com
Mutations in the orphan transporter MFSD7c (also known as Flvcr2), are linked to Fowler
syndrome. Here, we used Mfsd7c knockout (Mfsd7c–/–) mice and cell-based assays to …

Positron emission tomography imaging of tumor cell metabolism and application to therapy response monitoring

A Challapalli, EO Aboagye - Frontiers in oncology, 2016 - frontiersin.org
Cancer cells do reprogram their energy metabolism to enable several functions, such as
generation of biomass including membrane biosynthesis, and overcoming bioenergetic and …

Metabolomics approaches in pancreatic adenocarcinoma: tumor metabolism profiling predicts clinical outcome of patients

S Battini, F Faitot, A Imperiale, AE Cicek, C Heimburger… - BMC medicine, 2017 - Springer
Abstract Background Pancreatic adenocarcinomas (PAs) have very poor prognoses even
when surgery is possible. Currently, there are no tissular biomarkers to predict long-term …

Imaging tumor metabolism using positron emission tomography

DY Lewis, D Soloviev, KM Brindle - The Cancer Journal, 2015 - journals.lww.com
Positron emission tomography (PET) is an extraordinarily sensitive clinical imaging modality
for interrogating tumor metabolism. Radiolabeled PET substrates can be traced at …

Metabolic imaging of pancreatic ductal adenocarcinoma detects altered choline metabolism

MF Penet, T Shah, S Bharti, B Krishnamachary… - Clinical Cancer …, 2015 - AACR
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is an aggressive and lethal disease
that develops relatively symptom-free and is therefore advanced at the time of diagnosis …

Clinical translation of a click-labeled 18F-octreotate radioligand for imaging neuroendocrine tumors

SR Dubash, N Keat, P Mapelli, F Twyman… - Journal of Nuclear …, 2016 - Soc Nuclear Med
We conducted the first-in-human study of 18F-fluoroethyl triazole [Tyr3] octreotate (18F-FET-
βAG-TOCA) in patients with neuroendocrine tumors (NETs) to evaluate biodistribution …

The Effect of Deuteration on the Keto–enol Equilibrium and Photostability of the Sunscreen agent Avobenzone

RB Murphy, J Staton, A Rawal, TA Darwish - … & Photobiological Sciences, 2020 - Springer
The remarkable properties of deuterium have led to many exciting and favourable results in
enhancing material properties, for applications in the physical, medical, and biological …

[HTML][HTML] Near infrared fluorescent imaging of choline kinase alpha expression and inhibition in breast tumors

SP Arlauckas, M Kumar, AV Popov, H Poptani… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Choline kinase alpha (ChoKα) overexpression is associated with an aggressive tumor
phenotype. ChoKα inhibitors induce apoptosis in tumors, however validation of their …